More Biome Australia Ltd news
Biome Australia LtdASX: BIO

Clinical trial on asthma sufferers validates Biome probiotic

Feb 1, 2022 at 10:37 PM EST · Issued by Biome Australia Ltd

Filed with ASX · Feb 1, 2022 at 10:37 PM EST

On 6ix: 6ix.com/news/clinical-trial-on-asthma-sufferers-validates-biome-probiotic

Watch Biome Australia's latest call↗Biome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings Call↗

Biome Australia Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Biome Australia Ltd on 6ix

Earlier from Biome Australia

  • Investor UpdateDec 2, 2021

Later from Biome Australia

  • Successful acne clinical trial result with product to launchFeb 8, 2022
  • Supplementary announcement Acne clinical trialFeb 13, 2022
  • Biome Clinical Development UpdateFeb 20, 2022
  • Ethics approval received for Biome Daily Kids clinical trialFeb 23, 2022
  • Appendix 4D and Half Yearly ReportFeb 27, 2022
All Biome Australia news releases↗

Follow Biome Australia into a list and get an email when it puts out news.

Follow Biome Australia
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer